Sanofi has secured a significant milestone in its development of venglustat, an innovative oral glucosylceramide synthase inhibitor (GCSi), with the…
Read More
Pfizer and Innovent Biologics Announce Landmark Global Collaboration for Oncology Pipeline, Valued Up to $10.5 Billion
In a significant move poised to accelerate the development of novel cancer treatments, global pharmaceutical giant Pfizer and leading Chinese…
Read More
Radiopharmaceutical Logistics Navigates Perilous Path Amidst Rapid Market Growth
The burgeoning field of radiopharmaceutical therapies, once confined to niche applications, is rapidly ascending to become a mainstream pillar of…
Read More
NICE Recommends Nucala for Severe Asthma and COPD, Expanding Access to Advanced Biologic Therapy in the UK
In a significant development for respiratory healthcare in the United Kingdom, the National Institute for Health and Care Excellence (NICE)…
Read More
Scaling GLP-1 Obesity Trials Without Losing DXA Data
The explosive growth of global obesity trials, fueled by the success of GLP-1 receptor agonist therapies, presents a critical challenge:…
Read More
The Strait of Hormuz Blockades Ignite Global Healthcare Cost Crisis and Exacerbate Inequality
Ongoing geopolitical tensions and trade disruptions emanating from the Strait of Hormuz are precipitating a severe and escalating global healthcare…
Read More
The Hereditary Angioedema Pharmaceutical Landscape Poised for Unprecedented Expansion Driven by Late-Stage Pipeline and Emerging Technologies
The pharmaceutical landscape for hereditary angioedema (HAE) is on the cusp of a significant transformation, marked by an unprecedented surge…
Read More
Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.
After a period of post-pandemic uncertainty and uneven growth, a closely monitored metric of biopharmaceutical research and development (R&D) productivity…
Read More
Japan’s Pharmaceutical Market Embraces Speed and Execution Amidst Global Pressures
Japan’s pharmaceutical industry, the world’s third-largest by market value, is undergoing a significant and visible transformation. Historically characterized by methodical…
Read More
SK bioscience and VECOL Forge Strategic Partnership to Bolster Vaccine Self-Sufficiency in Colombia
SK bioscience has signed a significant vaccine technology transfer and manufacturing agreement with Colombia’s state-owned pharmaceutical company, VECOL. This collaboration…
Read MoreYOU MAY HAVE MISSED
